Exploring the ticagrelor-statin interplay in the PLATO trial

Cardiology (Switzerland)

Volumn 124, Issue 2, 2013, Pages 105-107

  DiNicolantonio, James J ^a   Serebruany, Victor L ^b  

^a Wegmans Pharmacy   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Acute coronary syndromes; Clopidogrel; Dosing; Mortality; Statins; Ticagrelor

Indexed keywords

ATORVASTATIN; CLOPIDOGREL; CREATINE KINASE; CYTOCHROME P450 3A4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TICAGRELOR; TROPONIN I;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DRUG EXPOSURE; DRUG POTENCY; ENZYME BLOOD LEVEL; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; META ANALYSIS (TOPIC); MORBIDITY; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84873580229     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000346151     Document Type: Review

References (6)

1. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, the PLATO Investigators: Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057.
2. The FDA ticagrelor review of complete response. http://www.accessdata.fda.gov/drugsatfda-docs/nda/2011/022433Orig1s000TOC. cfm (accessed May 10, 2012).
3. Cholesterol Treatment Trialists' (CTT) Collaboration: Efficacy and safety of intensive LDL-cholesterol-lowering therapy: a metaanalysis of data from 170,000 participants in Randomised trials. Lancet 2010; 376: 1670-1681.
4. Cannon CP, Braunwald E, McCabe CH, et al: Intensive versus moderate lipid lowering with statins after acute coronary syndormes. N Engl J Med 2004; 350: 1495-1504.
5. Ticagrelor (Brilique). Summary of product characteristics. 2010 http://www.ema.europa. eu/docs/en-GB/document-library/EPAR-Product-Information/human/001241/WC500100494.pdf (accessed May 11, 2012).
6. Di Sciascio G, Patti G, Pasceri V, et al: Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54: 558-565.